Share chart Bausch Health Companies Inc.
Extended chart
Simple chart
About Bausch Health Companies Inc.
Bausch Health Companies Inc. вместе со своими дочерними компаниями разрабатывает, производит и продает ряд фармацевтических препаратов, медицинских устройств и безрецептурных (OTC) продуктов, в первую очередь в терапевтических областях здоровья глаз, гастроэнтерологии и дерматологии. Компания работает в пяти сегментах: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics и Diversified Products. Сегмент Bausch + Lomb предлагает продукты, ориентированные на уход за зрением, хирургические и потребительские, хирургические и офтальмологические фармацевтические продукты. more detailsMain settings
IPO date
1994-03-29
ISIN
CA0717341071
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
1.36
Дивиденд ао
1.19
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 0.2989 | 10 |
| P/BV | -8.83 | 0 |
| P/E | 10.68 | 9 |
Efficiency
| Title | Value | Grade |
| ROA | -0.1626 | 0 |
| ROE | 3.81 | 1 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0.6429 | 6.43 |
| Average dividend growth | 20.71 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 13.98 | 0 |
| Debt/Ratio | 0.815 | 9 |
| Debt/Equity | -16.9 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 18.57 | 3 |
| Yield Ebitda, % | -36.22 | 0 |
| Yield EPS, % | -92.47 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 5.98 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 4.86 $ | 4.86 $ | 5.98 $ | 23.05 % | 0 % | 0 % |
| Month | 4.45 $ | 4.45 $ | 5.98 $ | 34.38 % | 0 % | 0 % |
| Three month | 4.37 $ | 4.32 $ | 7.27 $ | 36.84 % | 0 % | 0 % |
| Half a year | 7.34 $ | 4.32 $ | 8.06 $ | -18.53 % | 0 % | 0 % |
| Year | 5.96 $ | 4.32 $ | 9.78 $ | 0.34 % | 0 % | 0 % |
| 3 years | 5.97 $ | 4.32 $ | 10.61 $ | 0.17 % | 0 % | 0 % |
| 5 years | 17.26 $ | 4.32 $ | 34.38 $ | -65.35 % | 0 % | 0 % |
| 10 years | 228.49 $ | 4.32 $ | 262.52 $ | -97.38 % | 0 % | 0 % |
| Year to date | 6.16 $ | 4.32 $ | 7.94 $ | -2.92 % | 0 % | 0 % |
Insider trading
Main owners
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Thomas J. Appio | CEO & Director | 4.73M | 1962 (63 years) |
| Mr. Mirza Dautbegovic | Executive VP & COO | N/A | |
| Ms. Seana Carson | Executive VP & General Counsel | 720.5k | 1973 (52 years) |
| Ms. Kathleen Fitzpatrick | Executive VP and Chief HR & Communications Officer | N/A | |
| Dr. Tage Ramakrishna M.D. | Chief Medical Officer and President of R&D | N/A | 1974 (51 year) |
| Mr. Cees Heiman | Senior Vice President of Europe & Canada | N/A | |
| Mr. Jean-Jacques Charhon | Chief Financial Officer | 1965 (60 years) | |
| Mr. Donald Pearl | Senior Vice President of Ortho Dermatologics | ||
| Ms. Jiny Kim M.B.A. | Senior Vice President of Solta Medical | 1977 (48 years) | |
| Mr. Jeff S. Hartness | Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs |
About company
Address: Canada, Laval. QC HL A, 2150 St. ElzEar Boulevard West - Open in google maps, Open in yandex maps
Website: https://www.bauschhealth.com
Website: https://www.bauschhealth.com
